4D pharma plc was a clinical-stage pharmaceutical company renowned for its pioneering work in the research and development of Live Biotherapeutic Products (LBPs), a novel class of medicines derived from the human microbiome. The company's mission was to develop therapies for a wide range of serious unmet medical conditions, including various cancers (e.g., renal cell carcinoma, pancreatic cancer, lung cancer), gastrointestinal disorders, respiratory diseases like asthma, and central nervous system conditions. 4D pharma utilized its proprietary MicroRx® platform to rationally identify and develop single-strain LBP candidates. In June 2022, 4D pharma plc entered administration. Subsequently, in March 2023, its key assets, intellectual property, and certain research personnel were acquired by Armata Pharmaceuticals, integrating 4D's LBP programs and discovery capabilities.
The Leeds headquarters primarily served as the corporate, administrative, and strategic hub for the company's global operations, including clinical development oversight, financial management, and investor relations before its administration.
The Leeds office was a modern leased office space within a commercial building, facilitating corporate functions. More notable were its specialized research facilities in Aberdeen, Scotland, equipped for microbiome research, and its GMP-certified manufacturing plant in León, Spain, which were critical to its LBP development.
Prior to administration, 4D pharma plc likely fostered a highly innovative, research-driven, and collaborative work culture typical of pioneering biotech firms. There was a strong focus on scientific discovery in the microbiome field and the development of novel LBP therapies for unmet medical needs, attracting talent passionate about this cutting-edge area of medicine.
The Leeds HQ was significant as the central command for 4D pharma's ambitious strategy to develop and commercialize a new class of therapeutics. It oversaw all corporate functions, R&D direction (in conjunction with Aberdeen), management of extensive clinical trial programs across multiple indications, and its manufacturing scale-up efforts in Spain.
While headquartered in the UK with key research operations in Scotland and manufacturing in Spain, 4D pharma plc had a global operational footprint. This was primarily driven by its extensive clinical trial programs conducted across multiple countries, including sites in North America (USA, Canada) and Europe. The company also engaged in international collaborations with academic institutions and research organizations, and its investor base was international, reflecting its ambition to bring novel LBP therapies to patients worldwide.
9 Bond Court
Leeds
West Yorkshire
United Kingdom
Address: Life Sciences Innovation Building, Foresterhill Health Campus, Aberdeen, AB25 2ZS, Scotland
The Aberdeen facility leveraged Scotland's strong life sciences ecosystem, including proximity to the University of Aberdeen, to drive innovation in microbiome research and build the company's LBP pipeline.
Address: Parque Tecnológico de León, Parcelas M-1 y M-2, 24009 León, Spain
To establish robust, scalable, in-house manufacturing capabilities in Europe for LBPs, ensuring quality control and supply for global clinical trials and future commercialization efforts.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 4D pharma plc' leadership includes:
4D pharma plc has been backed by several prominent investors over the years, including:
Following 4D pharma plc's entry into administration in June 2022 and the subsequent acquisition of its assets by Armata Pharmaceuticals in March 2023, the executive team of 4D pharma plc as a standalone entity ceased to operate. The primary executive 'news' in the relevant period pertains to the conclusion of their roles at 4D pharma plc.
Discover the tools 4D pharma plc uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Historically, 4D pharma plc likely utilized standard corporate email formats. Common patterns included first initial followed by last name, or first name separated from last name by a period. Given the company's administration and subsequent asset acquisition, these email addresses are no longer active.
[first_initial][last]@4dpharmaplc.com or [first].[last]@4dpharmaplc.com
Format
jdoe@4dpharmaplc.com or jane.doe@4dpharmaplc.com
Example
0 (Company emails are inactive)%
Success rate
Armata Pharmaceuticals • March 27, 2023
Armata Pharmaceuticals, Inc. announced it has completed its acquisition of the assets of 4D Pharma PLC and its UK subsidiary, 4D Pharma Research Limited, including 4D's therapeutic programs, its MicroRx® LBP discovery platform and its LBP-focused intellectual property portfolio. Key 4D pharma R&D staff also joined Armata....more
Fierce Biotech • June 24, 2022
Live biotherapeutics biotech 4D pharma has had its shares suspended on the London Stock Exchange and has appointed administrators after failing to secure additional funding. The company had warned earlier in the week that it was running out of cash....more
Endpoints News • February 1, 2023
Armata Pharmaceuticals announced it would acquire certain assets of 4D Pharma, which filed for a UK version of bankruptcy in June 2022. The deal includes 4D's therapeutic programs and its MicroRx discovery platform....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 4D pharma plc, are just a search away.